Ocaratuzumab: A New Hope for Autoimmune Diseases? A emerging approach, ocaratuzumab, appears to present promising benefits for individuals living with various autoimmune conditions. Experts hypothesize that the distinct mechanism of action, targeting the key population of B cells, could effectively reduce swelling and slow disease wors… Read More

Recent research have the efficacy of RMP1-14, a specifically engineered anti-mouse PD-1 antibody , for enhancing cancer immune response . Unlike existing approaches, RMP1-14 exhibits superior interaction to murine PD-1, leading to robust lymphocyte engagement and subsequent neoplastic elimination in experimental models . Further investigation of… Read More

Feladilimab, known as GSK3359609, represents a significant advance in immune treatment. This engineered monoclonal antibody specifically targets {CD47|, the "don't eat me" signal, a molecule expressed on multiple cell types. By inhibiting CD47's binding with SIRPα on immune cells, feladilimab enhances phagocytosis of cancer cells, ultimately eli… Read More

Cancer remains a significant global health challenge, with chronic inflammation often playing a role in tumor development and progression. , Therefore, the search for novel anti-inflammatory agents to complement conventional cancer therapies is vital. Triiptolide, a synthetic derivative of the natural product triptolide, has emerged as a promisi… Read More

Hyaluronidase, identified by the specific identifier 37326-33-3, constitutes a fascinating protein increasingly recognized for its diverse applications. Historically, it garnered attention for its crucial role in promoting tissue regeneration and hydrolyzing hyaluronic acid, a key substance of the extracellular matrix. New research indicates its… Read More